|
2019
|
Invention
|
Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing s... |
|
|
Invention
|
Enhanced eductor design.
The present invention provides for an enhanced eductor element that sig... |
|
2017
|
Invention
|
8'-hydroxy-dihydroergotamine compounds and compositions.
8′-Hydroxy-Dihydroergotamine (8′-OH DHE... |
|
|
Invention
|
Headache pre-emption by dihydroergotamine treatment during headache precursor events.
Disclosed ... |
|
2016
|
Invention
|
Dose counter with lockout mechanism.
A medicament dispenser, in particular a metered dose inhale... |
|
2015
|
Invention
|
Enhanced eductor design. The present invention provides for an enhanced eductor element that sign... |
|
|
Invention
|
Methods and apparatus for delivering aerosolized medication.
A pulmonary drug delivery device ha... |
|
|
Invention
|
Fluoroergoline analogs. 2B receptors using the compounds and compositions disclosed herein. |
|
|
Invention
|
Aerosol composition for administering drugs.
Described here are compositions and methods for the... |
|
|
Invention
|
Administration of dihydroergotamine mesylate particles using a metered dose inhaler.
Disclosed a... |
|
|
Invention
|
Novel ergoline derivatives and uses thereof.
Provided herein are 8′-Hydroxy-2-CF3-dihydroergotam... |
|
|
Invention
|
Novel cabergoline derivatives.
Provided herein are novel cabergoline analogs and compositions th... |
|
|
Invention
|
Fluoroergoline derivatives and uses thereof.
Provided herein are novel fluoroergoline derivative... |
|
2014
|
Invention
|
Novel methysergide derivatives.
Provided herein are novel methysergide derivatives and compositi... |
|
|
Invention
|
Method of using dihydroergotamine for pre-emptive treatment of migraine.
The invention is drawn ... |
|
|
Invention
|
Methods for administering corticosteroid formulations.
Described here are methods for the treatm... |
|
|
Invention
|
Pulmonary administration of rotigotine.
Provided herein are methods and compositions for produci... |
|
|
Invention
|
Sustained-release formulation of rotigotine.
Provided herein are methods and compositions for pr... |
|
|
Invention
|
Pulmonary administration of rotigotine. Provided herein are methods and compositions for producin... |
|
|
Invention
|
Sustained-release formulation of rotigotine. Provided herein are methods and compositions for pro... |
|
|
Invention
|
Novel substituted indolo 4,3 fg quinolines useful for treating migraine.
Provided herein are nov... |
|
|
Invention
|
Dose counter with lockout mechanism. A medicament dispenser, in particular a metered dose inhaler... |
|
2013
|
Invention
|
Novel methysergide derivatives. Provided herein are novel methysergide derivatives and compositio... |
|
|
Invention
|
Fluoroergoline derivatives and uses thereof. Provided herein are novel fluoroergoline derivatives... |
|
|
Invention
|
Methysergide derivatives. 1A receptor using the compounds and compositions disclosed herein. |
|
|
Invention
|
8'-hydroxy-dihydroergotamine compounds and compositions. 8'-HydiOxy-Dihydroergotamine (8'-OH DHE)... |
|
|
Invention
|
Novel ergoline derivatives and uses thereof. Provided herein are 8'-Hydroxy-2-CF3-dihydroergotami... |
|
|
Invention
|
8'-hydroxy-dihydroergotamine compounds and compositions. 8'-Hydroxy-Dihydroergotamine (8'-OH DHE)... |
|
|
Invention
|
8′-hydroxy-dihydroergotamine compounds and compositions. 8′-Hydroxy-Dihydroergotamine (8′-OH DHE)... |
|
|
Invention
|
Synthesis of small particles.
The invention provides an apparatus for forming fine particles of ... |
|
|
Invention
|
Iso-ergoline derivatives. 2B receptors using the compounds and compositions disclosed herein. |
|
|
Invention
|
Corticosteroid particles and method of production.
A new particle morphology of glucocorticoster... |
